BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3541 related articles for article (PubMed ID: 29262506)

  • 21. Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC.
    Ma C; Chi M; Su H; Cheng X; Chen L; Kan Y; Wei W; Huang X; Li Y; Li L; Lin K; Huang Y; Wu Y; Huang X; Huang A; Liu J
    Hepatogastroenterology; 2012 Oct; 59(119):2104-11. PubMed ID: 23435129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
    Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
    BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
    Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
    Ma WJ; Wang HY; Teng LS
    World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
    An SL; Xiao T; Wang LM; Rong WQ; Wu F; Feng L; Liu FQ; Tian F; Wu JX
    Asian Pac J Cancer Prev; 2015; 16(10):4421-7. PubMed ID: 26028108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of prognostic factors in patients with hepatocellular carcinoma (≤5 cm) underwent hepatectomy].
    Rong W; Yu W; Wu J; Wu F; Wang L; Tian F; An S; Feng L
    Zhonghua Wai Ke Za Zhi; 2016 Feb; 54(2):89-93. PubMed ID: 26876073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients.
    Harada N; Shirabe K; Maeda T; Kayashima H; Ishida T; Maehara Y
    World J Surg; 2015 Apr; 39(4):1044-51. PubMed ID: 25446481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
    Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
    Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 32. A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.
    Xia Y; Yan ZL; Xi T; Wang K; Li J; Shi LH; Wu MC; Shen F
    Hepatogastroenterology; 2012 Oct; 59(119):2248-54. PubMed ID: 22366528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.
    Lewis RH; Glazer ES; Bittenbinder DM; O'Brien T; Deneve JL; Shibata D; Behrman SW; Vanatta JM; Satapathy SK; Dickson PV
    J Gastrointest Cancer; 2019 Dec; 50(4):808-815. PubMed ID: 30117090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
    Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
    Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy.
    Wu SJ; Zhang ZZ; Cheng NS; Xiong XZ; Yang L
    Surg Oncol; 2019 Jun; 29():159-167. PubMed ID: 31196483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.
    Yang HJ; Guo Z; Yang YT; Jiang JH; Qi YP; Li JJ; Li LQ; Xiang BD
    World J Gastroenterol; 2016 Jun; 22(21):5088-95. PubMed ID: 27275101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas.
    Joliat GR; Labgaa I; Uldry E; Demartines N; Halkic N
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):792-796. PubMed ID: 29538038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
    Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
    BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 178.